Associated Papers
Developmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.
Burr R et al.
Nature Cancer, 2024
Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.
Wang Q et al.
Molecular Diagnosis & Therapy, 2024
Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Öfverholm I et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.
Zhang MS et al.
Plos One, 2024
Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas.
Pu X et al.
Cell & Bioscience, 2023
Detection and analysis of common pathogenic germline mutations in Peutz-Jeghers syndrome.
Gu GL et al.
World Journal of Gastroenterology, 2021
Precision medicine and actionable alterations in lung cancer: A single institution experience.
Mambetsariev I et al.
Plos One, 2020
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Lim SM et al.
Oncotarget, 2016
Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Sun S et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2015
Association between the epidermal growth factor gene polymorphism and endometriosis in women from Brazil.
Oliveira CB et al.
Genetics and Molecular Research : Gmr, 2014
Association between the epidermal growth factor +61 G/A polymorphism and glioma risk: a meta-analysis.
Chen X et al.
Plos One, 2014
EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y et al.
Gene, 2013
Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z et al.
Genetic Testing and Molecular Biomarkers, 2012
Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd et al.
Journal of Cancer Research and Clinical Oncology, 2012
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction.
Wang WP et al.
World Journal of Surgical Oncology, 2012
Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
Chen K et al.
Genetic Testing and Molecular Biomarkers, 2011
Association between EGF +61 G/A and glioma risk in a Chinese population.
Wang S et al.
Bmc Cancer, 2010
Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M et al.
Human Immunology, 2008
EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients.
Ribeiro R et al.
Journal of Neuro-oncology, 2007
Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.
Araújo A et al.
The Oncologist, 2007
Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population.
Bao G et al.
The Journal of International Medical Research, 0
Genetic polymorphisms and endometriosis: contribution of genes that regulate vascular function and tissue remodeling.
Trovó de Marqui AB
Revista Da Associacao Medica Brasileira (1992), 0